{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:16:53Z","timestamp":1789993013225,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biochemistry and Biotechnology, University of Thessaly"},{"DOI":"10.13039\/100010661","name":"EU H2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hellenic State Scholarships Foundation"},{"DOI":"10.13039\/501100004895","name":"European Social Fund (ESF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Resources"},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"publisher","award":["PD105808"],"award-info":[{"award-number":["PD105808"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"publisher","award":["PD 121406"],"award-info":[{"award-number":["PD 121406"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejmech.2018.01.095","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T12:18:58Z","timestamp":1517573938000},"page":"266-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A multidisciplinary study of 3-(\u03b2- d -glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors"],"prefix":"10.1016","volume":"147","author":[{"given":"S\u00e1ndor","family":"Kun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaida","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Kyriakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia C.V.","family":"Stamati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Barkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Szennyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Bokor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin E.","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Stravodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Docsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Gergely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Moffatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto S.","family":"Patraskaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Kokolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkistis","family":"Gkerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki T.","family":"Skamnaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetres D.","family":"Leonidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Soms\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.095_bib1","unstructured":"World Health Organisation. www.who.int (accessed 12\/12\/2017)."},{"key":"10.1016\/j.ejmech.2018.01.095_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.01.095_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389203023380422","article-title":"Glycogen phosphorylase as a molecular target for type 2 diabetes therapy","volume":"3","author":"Oikonomakos","year":"2002","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejmech.2018.01.095_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11101-014-9360-6","article-title":"Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes","volume":"13","author":"Hayes","year":"2014","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.ejmech.2018.01.095_bib5","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.2174\/092986708786848659","article-title":"New inhibitors of glycogen phosphorylase as potential antidiabetic agents","volume":"15","author":"Soms\u00e1k","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib6","series-title":"Discovery and Development of Antidiabetic Agents from Natural Products","first-page":"29","article-title":"Computer-aided discovery of glycogen phosphorylase inhibitors exploiting natural products","author":"Hayes","year":"2017"},{"key":"10.1016\/j.ejmech.2018.01.095_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1110\/ps.041216105","article-title":"Kinetic and crystallographic studies on 2-(\u03b2-d-glucopyranosyl)-5-methyl-1,3,4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site","volume":"14","author":"Chrysina","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2018.01.095_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.fct.2014.01.055","article-title":"Biochemical and biological assessment of the inhibitory potency of extracts from vinification byproducts of Vitis vinifera extracts against glycogen phosphorylase","volume":"67","author":"Kantsadi","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2018.01.095_bib9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/0929867324666161118122534","article-title":"Phytogenic polyphenols as glycogen phosphorylase inhibitors: the potential of triterpenes and flavonoids for glycaemic control in type 2 diabetes","volume":"24","author":"Stravodimos","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/cmdc.201100533","article-title":"The \u03c3-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b","volume":"7","author":"Kantsadi","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.01.095_bib11","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.bmc.2014.06.058","article-title":"Structure based inhibitor design targeting glycogen phosphorylase b. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-\u03b2-d-glucopyranosylamines","volume":"22","author":"Parmenopoulou","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib12","first-page":"477","article-title":"Effect of glucopyranosylidene-spiro-thiohydantoin on glycogen metabolism in liver tissues of streptozotocin-induced and obese diabetic rats","volume":"4","author":"Docsa","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2018.01.095_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069420","article-title":"Glycogen phosphorylase inhibitor N-(3,5-dimethyl-benzoyl)-N\u2019-(\u03b2-d-glucopyranosyl) urea improves glucose tolerance under normoglycemic and diabetic conditions through rearranging hepatic metabolism","volume":"8","author":"Nagy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.01.095_bib14","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1073\/pnas.95.4.1776","article-title":"Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in\u00a0vivo","volume":"95","author":"Martin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.01.095_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejmech.2015.12.004","article-title":"Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition","volume":"108","author":"Goyard","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib16","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2174\/1568026615666150622091407","article-title":"Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats","volume":"15","author":"Docsa","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.2174\/1389557511009011188","article-title":"Pharmacological manipulation of brain glycogenolysis as a therapeutic approach to cerebral ischemia","volume":"10","author":"Xu","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bcp.2014.09.001","article-title":"Glycogen metabolism in cancer","volume":"92","author":"Zois","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.095_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jnr.22671","article-title":"Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT-1 up-regulation","volume":"89","author":"Guan","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ejmech.2018.01.095_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.crci.2010.09.004","article-title":"Glucose derived inhibitors of glycogen phosphorylase","volume":"14","author":"Soms\u00e1k","year":"2011","journal-title":"Compt. Rendus Chim."},{"key":"10.1016\/j.ejmech.2018.01.095_bib21","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2174\/1389557511009011102","article-title":"Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site","volume":"10","author":"Praly","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib22","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1021\/acs.jmedchem.7b01056","article-title":"Nanomolar inhibitors of glycogen phosphorylase based on \u03b2-D-glucosaminyl heterocycles: a combined synthetic, enzyme kinetic, and protein crystallography study","volume":"60","author":"Bokor","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejmech.2014.02.041","article-title":"New synthesis of 3-(\u03b2-d-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase","volume":"76","author":"Kun","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/ml4001529","article-title":"C-Glucopyranosyl-1,2,4-triazoles as new potent inhibitors of glycogen phosphorylase","volume":"4","author":"Bokor","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.095_bib25","unstructured":"Schr\u00f6dinger, in, LLC, New York, NY, 2014."},{"key":"10.1016\/j.ejmech.2018.01.095_bib26","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.01.095_bib27","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2018.01.095_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jmgm.2015.01.009","article-title":"Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets","volume":"57","author":"Xu","year":"2015","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2018.01.095_bib29","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1021\/ci400025f","article-title":"CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric series","volume":"53","author":"Damm-Ganamet","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.01.095_bib30","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/jm0100279","article-title":"Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system","volume":"44","author":"Pearlman","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib31","series-title":"R: a Language and Environment for Statistical Computing in: R Foundation for Statistical Computing","author":"R.C. Team","year":"2017"},{"key":"10.1016\/j.ejmech.2018.01.095_bib32","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/jcc.21859","article-title":"Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime\/MM-GBSA calculation","volume":"32","author":"Du","year":"2011","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib33","article-title":"Quantum mechanical scoring for protein docking","volume":"131","author":"Cho","year":"2009","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2018.01.095_bib34","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1016\/j.bmc.2009.08.060","article-title":"Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors","volume":"17","author":"Benltifa","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib35","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/ci900231p","article-title":"Correlation between performance of QM\/MM docking and simple classification of binding sites","volume":"49","author":"Chung","year":"2009","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.01.095_bib36","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1063\/1.444267","article-title":"Self-consistent molecular-orbital methods. XXIII. A polarization-type basis set for second-row elements","volume":"77","author":"Francl","year":"1982","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2018.01.095_bib37","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1063\/1.1677527","article-title":"Self-consistent molecular-orbital methods. XII. Further extensions of Gaussian-Type basis sets for use in molecular-orbital studies of organic-molecules","volume":"56","author":"Hehre","year":"1972","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2018.01.095_bib38","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2018.01.095_bib39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron-density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.ejmech.2018.01.095_bib40","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/j100096a001","article-title":"Ab-initio calculation of vibrational absorption and circular-dichroism spectra using density-functional force-fields","volume":"98","author":"Stephens","year":"1994","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib41","doi-asserted-by":"crossref","first-page":"43620","DOI":"10.1039\/C5RA05702G","article-title":"Synthesis of 5-aryl-3-C-glycosyl- and unsymmetrical 3,5-diaryl-1,2,4-triazoles from alkylidene-amidrazones","volume":"5","author":"Sz\u0151cs","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.01.095_bib42","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1016\/j.tet.2017.05.014","article-title":"C-Glycosyl 1,2,4-triazoles: synthesis of the 3-\u03b2-d-glucopyranosyl-1,5-disubstituted and 5-\u03b2-d-glucopyranosyl-1,3-disubstituted variants","volume":"73","author":"Szab\u00f3","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.01.095_bib43","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1016\/j.tet.2013.09.099","article-title":"C-(\u03b2-d-Glucopyranosyl)formamidrazones, formic acid hydrazides and their transformations into 3-(\u03b2-d-glucopyranosyl)-5-substituted-1,2,4-triazoles: a synthetic and computational study","volume":"69","author":"Bokor","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.01.095_bib44","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.carres.2011.03.004","article-title":"Synthesis of variously coupled conjugates of D-glucose, 1,3,4-oxadiazole, and 1,2,3-triazole for inhibition of glycogen phosphorylase","volume":"346","author":"Kun","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2018.01.095_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tetasy.2004.11.064","article-title":"Anomeric \u03b1-azido acid (2-azido-2-deoxy-hept-2-ulopyranosonic acid) derivatives en route to peptides incorporating sugar amino acids","volume":"16","author":"Czifr\u00e1k","year":"2005","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1016\/j.ejmech.2018.01.095_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsb.2017.05.001","article-title":"Van der Waals interactions govern C-\u03b2-d-glucopyranosyl triazoles' nM inhibitory potency in human liver glycogen phosphorylase","volume":"199","author":"Kantsadi","year":"2017","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.ejmech.2018.01.095_bib47","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejmech.2012.06.029","article-title":"The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment","volume":"54","author":"Kantsadi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejmech.2016.06.049","article-title":"Synthetic, enzyme kinetic, and protein crystallographic studies of C-\u03b2-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase","volume":"123","author":"Kantsadi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib49","doi-asserted-by":"crossref","first-page":"10745","DOI":"10.1021\/bi00500a005","article-title":"Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b","volume":"29","author":"Martin","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.01.095_bib50","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1021\/bi00106a006","article-title":"Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes","volume":"30","author":"Martin","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.01.095_bib51","doi-asserted-by":"crossref","unstructured":"E. Kyriakis, T.G.A. Solovou, S. Kun, K. Czifr\u00e1k, B. Sz\u0151cs, L. Juh\u00e1sz, \u00c9. Bokor, G.A. Stravodimos, A.L. Kantsadi, D.S.M. Chatzileontiadou, V.T. Skamnaki, L. Soms\u00e1k, D.D. Leonidas, Probing the \u03b2-pocket of the active site of human liver glycogen phosphorylase with 3-(C-\u03b2-d-glucopyranosyl)-5-(4-substituted-phenyl)-1,2,4-triazole inhibitors (2017), in preparation.","DOI":"10.1016\/j.bioorg.2018.02.008"},{"key":"10.1016\/j.ejmech.2018.01.095_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2018.01.095_bib53","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0960-894X(00)00172-4","article-title":"Prediction of drug solubility from Monte Carlo simulations","volume":"10","author":"Jorgensen","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.095_bib54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","article-title":"Prediction of drug solubility from structure","volume":"54","author":"Jorgensen","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2018.01.095_bib55","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.bmc.2013.07.024","article-title":"Synthesis, enzyme kinetics and computational evaluation of N-(\u03b2-d-glucopyranosyl) oxadiazolecarboxamides as glycogen phosphorylase inhibitors","volume":"21","author":"Poly\u00e1k","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1039\/C4MD00335G","article-title":"Computationally motivated synthesis and enzyme kinetic evaluation of N-(\u03b2-d-glucopyranosyl)-1,2,4-triazolecarboxamides as glycogen phosphorylase inhibitors","volume":"6","author":"Begum","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2018.01.095_bib57","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib58","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cmdc.201200585","article-title":"Carboxylic acid (bio)isosteres in drug design","volume":"8","author":"Ballatore","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.01.095_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib60","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2174\/138955712803832654","article-title":"Carbohydrate based potential chemotherapeutic agents: recent developments and their scope in future drug discovery","volume":"12","author":"Tiwari","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib61","unstructured":"QikProp, in, Schr\u00f6dinger, LLC, New York, NY, 2012."},{"key":"10.1016\/j.ejmech.2018.01.095_bib62","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pK(a) values","volume":"7","author":"Sondergaard","year":"2011","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2018.01.095_bib63","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2018.01.095_bib64","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib65","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2174\/1389557511009011156","article-title":"Computation as a tool for glycogen phosphorylase inhibitor design","volume":"10","author":"Hayes","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0076-6879(62)05243-X","article-title":"Muscle Phosphorylase-B","volume":"5","author":"Fischer","year":"1962","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.ejmech.2018.01.095_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0167-4838(85)90257-2","article-title":"Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization","volume":"832","author":"Oikonomakos","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2018.01.095_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0003-2697(85)90229-5","article-title":"Assay of inorganic phosphate in the mild of pH range, suitable for measurement of glycogen phosphorylase activity","volume":"148","author":"Saheki","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib69","series-title":"GrafFit Version 6.0","author":"Leatherbarrow","year":"2007"},{"key":"10.1016\/j.ejmech.2018.01.095_bib70","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1016\/j.bmc.2010.09.039","article-title":"The binding of \u03b2-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors","volume":"18","author":"Alexacou","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.095_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"Xds, Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib72","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"CCP4","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib73","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1107\/S090744491200251X","article-title":"JLigand: a graphical tool for the CCP4 template-restraint library","volume":"68","author":"Lebedev","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S2052252514009324","article-title":"The PDB_REDO server for macromolecular structure model optimization","volume":"1","author":"Joosten","year":"2014","journal-title":"Iucrj"},{"key":"10.1016\/j.ejmech.2018.01.095_bib77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.095_bib79","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S0907444911007281","article-title":"Presenting your structures: the CCP4mg molecular-graphics software","volume":"67","author":"McNicholas","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T05:42:06Z","timestamp":1570686126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":79,"alternative-id":["S022352341830117X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.095","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multidisciplinary study of 3-(\u03b2-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}